You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 11, November 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Radiologic Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Transcranial Brain Sonography Findings in Discriminating Between Parkinsonism and Idiopathic Parkinson Disease

Uwe Walter, MD; Dirk Dressler, MD; Thomas Probst, MD; Alexander Wolters, MD; Mazen Abu-Mugheisib, MD; Matthias Wittstock, MD; Reiner Benecke, MD

Arch Neurol. 2007;64(11):1635-1640.

Background  In several pilot studies, transcranial brain sonography findings of substantia nigra and lenticular nucleus discriminated between idiopathic Parkinson disease (PD) and atypical parkinsonian disorders.

Objective  To study the use of transcranial brain sonography in excluding the diagnosis of idiopathic PD in patients with sporadic parkinsonism.

Design and Setting  All patients with parkinsonism admitted to our movement disorder clinic from January 1, 2003, through December 31, 2005, who fulfilled clinical diagnostic criteria for definite PD, probable parkinsonian variant of multiple-system atrophy (MSA-P), or probable progressive supranuclear palsy (PSP) were prospectively studied with transcranial brain sonography by an investigator blinded to clinical diagnoses.

Patients  Eligible patients included 138 with sporadic idiopathic PD (82 men and 56 women; mean ± SD age, 67.1 ± 9.8 years; mean ± SD disease duration, 7.5 ± 6.3 years; mean ± SD motor score on the Unified Parkinson Disease Rating Scale, 32.6 ± 18.1), 21 with MSA-P (10 men and 11 women; mean ± SD age, 65.4 ± 9.5 years; mean ± SD duration of disease, 3.1 ± 2.0 years; mean ± SD motor score, 33.5 ± 16.1), and 22 with PSP (13 men and 9 women; mean ± SD age, 71.2 ± 5.5 years; mean ± SD duration of disease, 3.4 ± 2.4 years; mean ± SD motor score, 46.2 ± 18.9). In 7 patients, transcranial brain sonography was not possible owing to insufficient temporal acoustic bone windows.

Main Outcome Measures  Sensitivity, specificity, and predictive value of transcranial brain sonography in indicating an atypical parkinsonian syndrome rather than idiopathic PD in patients with sporadic parkinsonism.

Results  Normal echogenic substantia nigra indicated MSA-P rather than PD (sensitivity, 90%; specificity, 98%; positive predictive value, 86%), whereas third-ventricle dilatation of more than 10 mm in combination with lenticular nucleus hyperechogenicity indicated PSP rather than PD (sensitivity, 84%; specificity, 98%; positive predictive value, 89%). Normal echogenic substantia nigra combined with lenticular nucleus hyperechogenicity indicated MSA-P or PSP (sensitivity, 59%; specificity, 100%; positive predictive value, 100%). In parkinsonism with age at onset younger than 60 years, normal echogenic substantia nigra alone indicated MSA-P or PSP (sensitivity, 75%; specificity, 100%; positive predictive value, 100%).

Conclusions  Distinct transcranial brain sonography findings can exclude the diagnosis of PD in patients with sporadic parkinsonism. Sonographic discrimination of atypical parkinsonian syndromes from PD is clearer in patients with onset of parkinsonism at younger than 60 years.


Author Affiliations: Departments of Neurology, University of Rostock, Rostock, Germany (Drs Walter, Dressler, Probst, Wolters, Abu-Mugheisib, Wittstock, and Benecke), and District Hospital Mainkofen, Deggendorf, Germany (Dr Probst).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
Borroni et al.
Neurology 2008;71:1796-1803.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.